Shanghai ZJ Bio-Tech Co. Ltd. A Asset Resilience Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A asset resilience ratio. Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has an Asset Resilience Ratio of 9.38% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688317 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shanghai ZJ Bio-Tech Co. Ltd. A (2014–2025)
Asset resilience ratio of Shanghai ZJ Bio-Tech Co. Ltd. A from 2014 to 2025. This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Asset Resilience Ratio has changed over time. Read debt load of Shanghai ZJ Bio-Tech Co. Ltd. A for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shanghai ZJ Bio-Tech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688317 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥342.94 Million | 9.38% |
| Total Liquid Assets | CN¥342.94 Million | 9.38% |
Asset Resilience Insights
- Limited Liquidity: Shanghai ZJ Bio-Tech Co. Ltd. A maintains only 9.38% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai ZJ Bio-Tech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai ZJ Bio-Tech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Shanghai ZJ Bio-Tech Co. Ltd. A Asset Resilience Ratio by Year (2014–2025)
Shanghai ZJ Bio-Tech Co. Ltd. A asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for Shanghai ZJ Bio-Tech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.24% | CN¥347.89 Million ≈ $50.91 Million |
CN¥3.76 Billion ≈ $550.76 Million |
+6.60pp |
| 2014-12-31 | 2.64% | CN¥5.28 Million ≈ $772.52K |
CN¥199.63 Million ≈ $29.21 Million |
-- |
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.